Neon Therapeutics Inc (NASDAQ:NTGN) has been given a consensus recommendation of “Buy” by the ten brokerages that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have […]
Read More